Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.
Saved in:
| Title: | Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations. |
|---|---|
| Authors: | Broesby‐Olsen, S.1 sigurd.broesby-olsen@rsyd.dk, Vestergaard, H.2, Mortz, C. G.1, Jensen, B.1, Havelund, T.3, Hermann, A. P.4, Siebenhaar, F.5, Møller, M. B.6, Kristensen, T. K.6, Bindslev‐Jensen, C.1, Mastocytosis Centre Odense University Hospital (MastOUH) |
| Source: | Allergy. Jan2018, Vol. 73 Issue 1, p230-238. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 01054538 |
|---|---|
| DOI: | 10.1111/all.13237 |
